Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer
Clinical trial NCT05747326 · UNKNOWN
Trial details
- NCT number
- NCT05747326
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.